Sheng Wang | Drug Design | Best Researcher Award

Posted on by ScienceFather

🌟Prof. Sheng Wang, Drug Design, Best Researcher Award🏆

 Professor at Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, CAS, China

Sheng Wang, PhD, is a renowned molecular biologist and pharmacologist with expertise in structural-based drug design. He received his Doctor of Philosophy (PhD) in Molecular and Cell Biology from the University of Chinese Academy of Sciences. Currently, he serves as a Professor at the Center for Excellence in Molecular Cell Science at the Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences. Dr. Wang has made significant contributions to the field through his research on G protein-coupled receptors (GPCRs) and small molecule regulators for signaling pathways.

Author Metrics:

Google Scholar Profile

Dr. Wang’s publications have garnered significant attention and citations within the scientific community. His research articles have been published in top-tier journals such as Cell, Nature, Science, and PNAS. The impact of his work is evidenced by his high citation count and the recognition of his papers as cover stories in prestigious journals.

Citations: Dr. Wang’s research has been cited 3,591 times, indicating a significant impact within the scientific community. Citations reflect the extent to which other researchers have referenced Dr. Wang’s work in their own studies, suggesting its importance and relevance to the field.

h-index: Dr. Wang’s h-index is 16, which means that he has published at least 16 papers that have each received at least 16 citations. The h-index provides a measure of both the productivity and impact of a researcher’s publications.

i10-index: Dr. Wang’s i10-index is 17, indicating that he has published at least 17 papers that have each received at least 10 citations. This index is particularly useful for measuring the productivity and impact of recent publications, as it focuses on the number of papers with a minimum of 10 citations.

Education:

Wang completed his Bachelor of Science (minor) at Wuhan University and a Bachelor of Science in Food Quality and Safety at Huazhong Agricultural University. He earned his PhD in Molecular and Cell Biology from the University of Chinese Academy of Sciences, focusing on molecular and cell biology, with a specialization in structural-based drug design.

Research Focus:

Dr. Wang’s research primarily revolves around structural-based drug design and understanding the molecular mechanisms of GPCR pharmacology and signaling. He has also contributed significantly to the discovery of small molecule regulators for key signaling pathways, such as the Wnt/β-catenin pathway. His work has implications for developing novel therapeutics for various diseases, including psychiatric disorders and cancer.

Professional Journey:

After completing his PhD, Dr. Wang pursued postdoctoral research at the University of North Carolina at Chapel Hill, where he investigated the structural basis of GPCR pharmacology and signaling. He later joined the Center for Excellence in Molecular Cell Science at the Chinese Academy of Sciences as a Principal Investigator, focusing on structural-based drug design.

Honors & Awards:

Dr. Wang has received recognition for his contributions to the field of molecular biology and pharmacology. His work has been acknowledged with honors and awards from prestigious institutions and professional societies. These accolades highlight his outstanding achievements and impact in the scientific community.

Publications Noted & Contributions:

Wang’s publications have made significant contributions to advancing our understanding of molecular pharmacology and drug design. Notable contributions include elucidating the structural basis of receptor activation, discovering novel small molecule regulators for signaling pathways, and developing new therapeutic strategies for psychiatric disorders and cancer.

Recognition of methamphetamine and other amines by trace amine receptor TAAR1

  • Authors: H Liu, Y Zheng, Y Wang, X He, P Xu, S Huang, Q Yuan, X Zhang, …
  • Journal: Nature
  • Volume/Issue: 1-3, 8, 2023

2-Phenylcyclopropylmethylamine Derivatives as Dopamine D2 Receptor Partial Agonists: Design, Synthesis, and Biological Evaluation

  • Authors: W Yan, L Fan, J Yu, R Liu, H Wang, L Tan, S Wang, J Cheng
  • Journal: Journal of medicinal chemistry
  • Volume/Issue: 64 (23), 17239-17258, 2021

Serotonin 2A Receptor (5-HT2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants

  • Authors: W Duan, D Cao, S Wang, J Cheng
  • Journal: Chemical Reviews
  • Volume/Issue: 4, 2023

Transformation of a Dopamine D2 Receptor Agonist to Partial Agonists as Novel Antipsychotic Agents

  • Authors: R Liu, J Qi, H Wang, L Fan, P Zhang, J Yu, L Tan, S Wang, J Cheng
  • Journal: Journal of Medicinal Chemistry
  • Volume/Issue: 66 (9), 6274-6287, 2023

Advances in structure-based drug design: The potential for precision therapeutics in psychiatric disorders

  • Authors: D Cao, P Zhang, S Wang
  • Journal: Neuron
  • Volume/Issue: 1, 2024

Research Timeline:

Wang’s research journey has been marked by significant milestones and achievements. Starting from his graduate studies, through his postdoctoral research, to his current position as a Principal Investigator, he has consistently made impactful contributions to the field of molecular biology and pharmacology. His research timeline showcases a progression of expertise and innovation in structural-based drug design.

Collaborations and Projects:

Dr. Wang has been involved in collaborative projects with leading researchers and institutions worldwide. These collaborations have facilitated interdisciplinary research and the exchange of ideas, leading to groundbreaking discoveries in molecular pharmacology and drug design. Wang’s involvement in collaborative projects underscores the importance of teamwork and knowledge sharing in advancing scientific research.

Febee Louka | Medicinal Chemistry | Best Researcher Award

Posted on by ScienceFather

🌟Prof. Febee Louka, Medicinal Chemistry, Best Researcher Award 🏆

  •  Professor at University of Louisiana at Lafayette, United States

Febee R. Y. Louka is a distinguished Professor of Chemistry at the University of Louisiana at Lafayette (ULL). With a Ph.D. in Analytical/Medicinal Chemistry from Ohio University, she has established herself as a leading figure in the field. Her expertise spans various areas, including synthesizing complex metal complexes, monitoring environmental pollution, and developing novel biosensors. Dr. Louka’s commitment to research, teaching, and service has earned her numerous accolades and positions of leadership within academia.

Author Metrics

Scopus Profile

ORCID Profile

Dr. Louka’s contributions to scientific literature are substantial, with a prolific publication record and significant citations. Her work has been recognized for its impact on the field, as evidenced by her author metrics, including citation count, h-index, and publication output across prestigious journals.

Citations: Febee R. Y. Louka has received a total of 1,267 citations across 929 documents.

Documents: She has authored 54 documents indexed in Scopus.

h-index: The h-index is 22, indicating that Febee R. Y. Louka has published at least 22 papers that have each been cited at least 22 times.

Education

Febee Louka holds a Ph.D. in Analytical/Medicinal Chemistry from Ohio University, complemented by an M.Sc. and B.Sc. in Chemistry from Alexandria University, Egypt. Her academic journey has equipped her with a strong foundation in both theoretical knowledge and practical laboratory skills, enabling her to pursue cutting-edge research in her field.

Research Focus

Dr. Louka’s research focuses on several key areas, including the synthesis and characterization of metal complexes with potential applications in medicine and environmental remediation. She is also deeply involved in the development of biosensors for detecting pollutants and monitoring biological processes. Her interdisciplinary approach integrates chemistry, biology, and environmental science to address complex scientific challenges.

Professional Journey

Febee Louka’s professional journey encompasses a diverse range of roles, from teaching assistantships to tenure-track professorships. With positions at both Ohio University and ULL, she has demonstrated a commitment to education and research excellence. Her career progression reflects her dedication to advancing knowledge and fostering the next generation of scientists.

Honors & Awards

Throughout her career, Dr. Louka has received numerous honors and awards for her outstanding contributions to academia. These accolades recognize her excellence in teaching, research, and service, as well as her leadership within the university community. Her sustained impact and recognition highlight her significant contributions to the field of chemistry.

Publications Noted & Contributions

Dr. Louka’s publications are noteworthy for their scientific rigor and innovative contributions to the field. Her research papers have appeared in leading journals and have been cited extensively by peers. Additionally, she has contributed to the advancement of scientific knowledge through her mentorship of students and participation in collaborative research projects.

Title: “Copper(II) and zinc(II) complexes bridged by benzenoid aromatic oxocarbon and dicarboxylate dianions”

Authors: Mautner, F.A., Fischer, R.C., Torvisco, A., Louka, F.R., Massoud, S.S.

Journal: Polyhedron, 2023, 234, 116327

Title: “Magnetostructural Properties of Some Doubly-Bridged Phenoxido Copper(II) Complexes”

Authors: Massoud, S.S., Louka, F.R., Dial, M.T., Handa, M., Mikuriya, M.

Journal: Molecules, 2023, 28(6), 2648

Title: “Dinuclear doubly bridged phenoxido copper(II) complexes as efficient anticancer agents”

Authors: Massoud, S.S., Louka, F.R., Salem, N.M.H., Dvořák, Z., Trávníček, Z.

Journal: European Journal of Medicinal Chemistry, 2023, 246, 114992

Title: “Miscellaneous dimensional coordination polymers and luminescence emission properties of cadmium(II)-pseudohalide complexes”

Authors: Mautner, F.A., Fischer, R.C., Salem, N.M.H., Louka, F.R., Massoud, S.S.

Journal: Inorganica Chimica Acta, 2022, 535, 120871

Title: “Identification of potent anticancer copper(ii) complexes containing tripodal bis[2-ethyl-di(3,5-dialkyl-1H-pyrazol-1-yl)]amine moiety”

Authors: Massoud, S.S., Louka, F.R., Dial, M.T., Dvořák, Z., Trávníček, Z.

Journal: Dalton Transactions, 2021, 50(33), pp. 11521–11534

Research Timeline

Febee Louka’s research timeline illustrates her evolution as a scientist and the progression of her research interests over time. From her early work on metal complex synthesis to her current focus on environmental monitoring and biosensor development, her research trajectory reflects a commitment to addressing pressing societal and scientific challenges.

Collaborations and Projects

Dr. Louka has engaged in numerous collaborative projects with researchers from diverse backgrounds. These collaborations have led to interdisciplinary breakthroughs and innovative solutions to complex problems. By working across disciplines, she has expanded the scope of her research and fostered fruitful partnerships within and beyond academia.